Carregant...
Malaria research and its influence on anti-malarial drug policy in Malawi: a case study
BACKGROUND: In 1993, Malawi changed its first-line anti-malarial treatment for uncomplicated malaria from chloroquine to sulfadoxine-pyrimethamine (SP), and in 2007, it changed from SP to lumefantrine-artemether. The change in 1993 raised concerns about whether it had occurred timely and whether it...
Guardat en:
| Publicat a: | Health Res Policy Syst |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4888534/ https://ncbi.nlm.nih.gov/pubmed/27246503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12961-016-0108-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|